Table 2 The statistic analyses of 29 pelvic GCT patients basing on the location group
From: Surgical treatment for pelvic giant cell tumor: a multi-center study
Categories | Type Ia | Type IIa | Type IIIa | Total | p |
|---|---|---|---|---|---|
Number, n (%) | 10 (34.5) | 11 (37.9) | 8 (27.6) | 29 (100) | – |
Age, year, means (SD) | 37.2 (9.3) | 36.8 (7.9) | 45.1 (9.5) | 39.2 (9.3) | 0.106 |
Age group, n (%) | 0.175 | ||||
<20 | 0 (0) | 1 (9.1) | 0 (0) | 1 (3.4) | |
20~29 | 1 (10.0) | 0 (0) | 1 (12.5) | 2 (6.9) | |
30~39 | 6 (60.0) | 5 (45.5) | 1 (12.5) | 12 (41.4) | |
40~49 | 1 (10.0) | 5 (45.5) | 3 (37.5) | 9 (31.0) | |
≥50 | 2 (20.0) | 0 (0) | 3 (37.5) | 5 (17.2) | |
Sex, n (%) | 0.160 | ||||
Male | 3 (30.0) | 5 (45.5) | 6 (75.0) | 14 (48.3) | |
Female | 7 (70.0) | 6 (54.5) | 2 (25.0) | 15 (51.7) | |
Treatment, n (%) | 0.691 | ||||
S (IL) | 2 (20.0) | 4 (36.4) | 2 (25.0) | 8 (34.5) | |
S (W) | 8 (80.0) | 7 (63.6) | 6 (75.0) | 21 (31.0) | |
Follow-up, months, means (SD) | 62.2 (38.0) | 75.5 (59.9) | 38.3 (15.3) | 59.0 (42.7) | 0.215 |
Recurrence, n (%) | 0.065 | ||||
Exist | 0 (0) | 3 (27.3) | 0 (0) | 3 (10.3) | |
None | 10 (100) | 8 (72.7) | 8 (100) | 26 (89.7) | |
Complication, n (%) | 0.010 | ||||
Exist | 1 (10.0) | 6 (54.5) | 0 (0) | 7 (24.1) | |
None | 9 (90.0) | 5 (45.5) | 8 (100) | 22 (75.9) | |
MSTS, means (SD) | 23.6 (2.4) | 20.2 (4.3) | 25.5 (2.3) | 22.8 (3.8) | 0.005 |